Related Experiment Video
Updated: May 12, 2026

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
[Excitation-Contraction coupling and intracellular calcium cycling in failing hearts]
Shinichi Okuda1, Masafumi Yano
1Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Japan.
Insights
Heart failure involves faulty excitation-contraction coupling due to altered calcium handling. Targeting calcium regulatory proteins offers a promising new therapeutic strategy for heart failure.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
Context:
- Heart failure (HF) pathogenesis involves impaired excitation-contraction coupling.
- Neurohormonal imbalances, like sympathetic nervous system and renin-angiotensin system activation, drive HF progression.
Purpose:
- To review the mechanisms of defective calcium (Ca2+) regulation in heart failure.
- To explore the clinical potential of targeting Ca2+ regulatory proteins for HF treatment.
Summary:
- Abnormalities in Ca2+ handling proteins, including reduced SR Ca2+-ATPase (SERCA2A) function and increased SR Ca2+ leak via cardiac ryanodine receptor (RyR2), contribute to contractile dysfunction in HF.
- Dysregulated intracellular Ca2+ impacts troponin C binding, actin-myosin cross-bridging, and signaling pathways, exacerbating HF.
- Diastolic Ca2+ leak can lead to arrhythmias and sudden cardiac death in HF patients.
Impact:
- Understanding Ca2+ dysregulation provides insights into HF pathophysiology.
- Targeting Ca2+ regulatory proteins represents a novel therapeutic avenue for heart failure.
- This research may lead to new treatments to improve cardiac function and reduce mortality in HF.
Abstract:
Alterations in Excitation-Contraction coupling have recently been shown to play a crucial role in the pathogenesis of heart failure (HF). In failing hearts, abnormalities of neurohormonal mechanisms, which were included chronic activation of the sympathetic nervous system or of the renin-angiotensin system result in structural and functional changes in the calcium (Ca(2 +) ) regulatory proteins. These changes include the decreased sarcoplasmic reticulum (SR) load, which could be caused by reduced SR Ca(2 +) -ATPase (SERCA2A) function and increased SR Ca(2 +) leak via cardiac ryanodine receptor (RyR2) , a functional defect in L-type Ca(2 +) channel and activation of the reversal mode of Na (+) /Ca(2 +) exchanger. The abnormal regulation of intracellular Ca(2 +) affects troponin C binding and actin-myosin cross bridging and modulates post signaling pathway, which in turn contributes to the contractile dysfunction of hearts and hence to the progression of HF. Moreover, diastolic Ca(2 +) leak may develop delayed after depolarization and triggered activity as a substrate for lethal arrhythmia and sudden cardiac death. In this review, we focus on the underlying mechanism of defective Ca(2 +) regulation in HF and on the possibility of proceeding to clinical application as a new treatment for HF by targeting Ca(2 +) regulatory proteins.
More Related Videos
09:26Optical Mapping of Intra-Sarcoplasmic Reticulum Ca2+ and Transmembrane Potential in the Langendorff-perfused Rabbit Heart
Published on: September 10, 2015
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Excitation-Contraction Coupling in Skeletal Muscles
When an action potential...
Heart Failure II: Pathophysiology
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Cross-bridge Cycle
Pathophysiology of Heart Failure
Heart Failure Drugs: Inotropic Agents